Difficulty: Medium
Average Score: 71%
Practice
Indicate the neuromuscular blocker, whose breakdown product readily crosses the blood-brain barrier and may cause seizures:
Correct answer
D
Rationale
In this question, the correct answer is D) Atracurium. Atracurium is metabolized in the body to laudanosine, which readily crosses the blood-brain barrier. Once in the brain, laudanosine can lead to central nervous system excitatory effects, potentially causing seizures.
Now, let's explore why the other options are incorrect:
A) Pancuronium: While pancuronium is a neuromuscular blocker, its breakdown products do not readily cross the blood-brain barrier to cause seizures.
B) Succinylcholine: Succinylcholine does not produce a breakdown product that readily crosses the blood-brain barrier to induce seizures. It is metabolized differently in the body.
C) Tubocurarine: Tubocurarine is not known to produce a breakdown product that easily crosses the blood-brain barrier and causes seizures.
Educational context: Understanding the pharmacology of neuromuscular blockers is crucial for healthcare professionals, especially those involved in anesthesia and critical care. Knowing the potential side effects and mechanisms of action of these medications helps in safe prescribing and administration practices. Atracurium's unique metabolite and its ability to cross the blood-brain barrier highlight the importance of selecting the appropriate neuromuscular blocker based on the patient's condition and potential risks.
Now, let's explore why the other options are incorrect:
A) Pancuronium: While pancuronium is a neuromuscular blocker, its breakdown products do not readily cross the blood-brain barrier to cause seizures.
B) Succinylcholine: Succinylcholine does not produce a breakdown product that readily crosses the blood-brain barrier to induce seizures. It is metabolized differently in the body.
C) Tubocurarine: Tubocurarine is not known to produce a breakdown product that easily crosses the blood-brain barrier and causes seizures.
Educational context: Understanding the pharmacology of neuromuscular blockers is crucial for healthcare professionals, especially those involved in anesthesia and critical care. Knowing the potential side effects and mechanisms of action of these medications helps in safe prescribing and administration practices. Atracurium's unique metabolite and its ability to cross the blood-brain barrier highlight the importance of selecting the appropriate neuromuscular blocker based on the patient's condition and potential risks.